1. Barreiro TJ, Perillo I. An approach to interpreting spirometry.
Am Fam Physician 2004;69(5):1107-1114.
2. Villegas R, Xiang YB, Cai Q, Fazio S, Linton M, Li H, et al. Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men.
Metab Syndr Relat Disord 2010;8(3):263-270.
3. Nicks ME, O'Brien MM, Bowler RP. Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers.
COPD 2011;8(4):264-269.
4. Durmus Kocak N, Sasak G, Aka Akturk U, Akgun M, Boga S, Sengul A, et al. Serum uric acid levels and uric acid/creatinine ratios in stable chronic obstructive pulmonary disease (COPD) patients: are these parameters efficient predictors of patients at risk for exacerbation and/or severity of disease.
Med Sci Monit 2016;22:4169-4176.
5. Aida Y, Shibata Y, Osaka D, Abe S, Inoue S, Fukuzaki K, et al. The relationship between serum uric acid and spirometric values in participants in a health check: the Takahata study.
Int J Med Sci 2011;8(6):470-478.
6. Bardin T, Richette P. Definition of hyperuricemia and gouty conditions.
Curr Opin Rheumatol 2014;26(2):186-191.
7. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends.
Lancet 2007;370(9589):765-773.
9. Kim Y, Kang J, Kim GT. Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample.
Clin Rheumatol 2018;37(9):2529-2538.
10. Gan WQ, Man SF, Sin DD. The interactions between cigarette smoking and reduced lung function on systemic inflammation.
Chest 2005;127(2):558-564.
11. Burchfiel CM, Marcus EB, Curb JD, Maclean CJ, Vollmer WM, Johnson LR, et al. Effects of smoking and smoking cessation on longitudinal decline in pulmonary function.
Am J Respir Crit Care Med 1995;151(6):1778-1785.
12. Shibata Y, Inoue S, Watanabe M. Impact of reduced pulmonary function in the Japanese general population: lessons from the Yamagata-Takahata study.
Respir Investig 2019;57(3):220-226.
14. Koran Centers for Disease Control and Prevention (KCDC). Korea National Health and Nutrition Examination Survey (KNHANES) [Internet]. Cheongju: KCDC; 2018;Accessed Jul 27, 2018]. Available from:
https://knhanes.cdc.go.kr/knhanes/main.do
15. Standardization of Spirometry, 1994 Update. American Thoracic Society.
Am J Respir Crit Care Med 1995;152(3):1107-1136.
16. Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population.
Tuberc Respir Dis 2005;58(3):230-242.
17. Sarangi R, Varadhan N, Bahinipati J, Dhinakaran A, Anandaraj , Ravichandran K. Serum uric acid in chronic obstructive pulmonary disease: a hospital based case control study.
J Clin Diagn Res 2017;11(9):BC09-BC13.
18. Song JU, Hwang J, Ahn JK. Serum uric acid is positively associated with pulmonary function in Korean health screening examinees.
Mod Rheumatol 2017;27(6):1057-1065.
19. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008.
Arthritis Rheum 2011;63(10):3136-3141.
20. Marangella M. Uric acid elimination in the urine. Pathophysiological implications.
Contrib Nephrol 2005;147:132-148.
21. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis.
Arthritis Care Res (Hoboken) 2010;62(2):170-180.
22. Kim JW, Kwak SG, Lee H, Kim SK, Choe JY, Park SH. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015.
Rheumatol Int 2017;37(9):1499-1506.
23. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome.
Circ J 2005;69(8):928-933.
24. Sung KC, Suh JY, Kim BS, Kang JH, Kim H, Lee MH, et al. High sensitivity C-reactive protein as an independent risk factor for essential hypertension.
Am J Hypertens 2003;16(6):429-433.
25. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis.
Thorax 2004;59(7):574-580.
26. Garcia-Pachon E, Padilla-Navas I, Shum C. Serum uric acid to creatinine ratio in patients with chronic obstructive pulmonary disease.
Lung 2007;185(1):21-24.
27. Zhang X, Liu L, Liang R, Jin S. Hyperuricemia is a biomarker of early mortality in patients with chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis 2015;10:2519-2523.
28. Bartziokas K, Papaioannou AI, Loukides S, Papadopoulos A, Haniotou A, Papiris S, et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD.
Eur Respir J 2014;43(1):43-53.